Callan Family Office’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.58M | Buy |
223,419
+156,628
| +235% | +$6.01M | 0.27% | 75 |
|
|
2025
Q1 | $2.59M | Buy |
66,791
+9,079
| +16% | +$352K | 0.19% | 110 |
|
|
2024
Q4 | $1.95M | Buy |
+57,712
| New | +$1.95M | 0.12% | 156 |
|
|
2023
Q2 | – | Sell |
-25,900
| Closed | -$922K | – | 132 |
|
|
2023
Q1 | $922K | Buy |
+25,900
| New | +$922K | 0.22% | 64 |
|